查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386130

傷寒疫苗市場報告：2030 年趨勢、預測與競爭分析

Typhoid Fever Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

傷寒疫苗趨勢與預測

預計到 2030 年，全球傷寒疫苗市場將達到 10 億美元，2024 年至 2030 年複合年成長率為 14.5%。該市場的主要驅動力是傷寒流行率的上升以及對具有預防多種疾病功效的組合疫苗的需求不斷成長。全球傷寒疫苗市場前景廣闊，醫院/診所市場和專科中心市場蘊藏商機。

傷寒疫苗市場洞察

Lucintel預測，莢膜多醣對於預防細菌感染非常有效，且安全、副作用少，可給藥或注射，使用簡單方便，預計在期內出現最高成長。

在這個市場中，醫院和診所預計將在預測期內實現最高成長。

由於各年齡層對疫苗的需求不斷增加以及對傷寒疫苗的認知較高，北美仍是最大的市場。

市場規模/估計：以金額的傷寒疫苗市場規模估計（10 億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔市場分析：依類型、給藥途徑、最終用途和地區金額（十億美元）估計傷寒疫苗市場規模。

區域分析：北美、歐洲、亞太地區和世界其他地區的傷寒疫苗市場區隔。

成長機會：依傷寒疫苗市場類型、給藥途徑、最終用途及地區進行成長機會分析。

策略分析：傷寒疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球傷寒疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球傷寒疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依類型分類的全球傷寒疫苗市場
    • 減毒活病毒疫苗
    • 莢膜多醣疫苗
    • 結合疫苗
    • 其他
  • 依給藥途徑的全球傷寒疫苗市場
    • 口服
    • 注射
  • 全球傷寒疫苗市場（依最終用途）
    • 醫院和診所
    • 專業中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球傷寒疫苗市場區域分佈
  • 北美傷寒疫苗市場
  • 歐洲傷寒疫苗市場
  • 亞太傷寒疫苗市場
  • 其他地區傷寒疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球傷寒疫苗市場成長機會
    • 依給藥途徑分類的全球傷寒疫苗市場成長機會
    • 全球傷寒疫苗市場成長機會（依最終用途）
    • 全球傷寒疫苗市場成長機會（依地區）
  • 全球傷寒疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球傷寒疫苗市場產能擴張
    • 全球傷寒疫苗市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • EMERGENT
  • Bio Farma
  • Bharat Biotech
  • BIO-MED
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Mylan
  • Teva Pharmaceutical
  • Sanofi
簡介目錄

Typhoid Fever Vaccine Trends and Forecast

The future of the global typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets. The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 14.5% from 2024 to 2030. The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.

A more than 150-page report is developed to help in your business decisions.

Typhoid Fever Vaccine by Segment

The study includes a forecast for the global typhoid fever vaccine by type, route of administration, end use, and region.

Typhoid Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccine
  • Conjugate Vaccine
  • Others

Typhoid Fever Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Injection

Typhoid Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Specialty Centers
  • Others

Typhoid Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Typhoid Fever Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies typhoid fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the typhoid fever vaccine companies profiled in this report include-

  • EMERGENT
  • Bio Farma
  • Bharat Biotech
  • BIO-MED
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Mylan
  • Teva Pharmaceutical
  • Sanofi

Typhoid Fever Vaccine Market Insights

Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.

Within this market, hospital & clinic is expected to witness highest growth over the forecast period.

North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.

Features of the Global Typhoid Fever Vaccine Market

Market Size Estimates: Typhoid fever vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Typhoid fever vaccine market size by type, route of administration, end use, and region in terms of value ($B).

Regional Analysis: Typhoid fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, route of administration, end uses, and regions for the typhoid fever vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the typhoid fever vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the typhoid fever vaccine market size?

Answer: The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030.

Q.2 What is the growth forecast for typhoid fever vaccine market?

Answer: The global typhoid fever vaccine market is expected to grow with a CAGR of 14.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the typhoid fever vaccine market?

Answer: The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.

Q4. What are the major segments for typhoid fever vaccine market?

Answer: The future of the typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets.

Q5. Who are the key typhoid fever vaccine market companies?

Answer: Some of the key typhoid fever vaccine companies are as follows:

  • EMERGENT
  • Bio Farma
  • Bharat Biotech
  • BIO-MED
  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Mylan
  • Teva Pharmaceutical
  • Sanofi

Q6. Which typhoid fever vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.

Q7. In typhoid fever vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the typhoid fever vaccine market by type (live attenuated vaccine, capsular polysaccharide vaccine, conjugate vaccine, and others), route of administration (oral and injection), end use (hospitals & clinics, specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Typhoid Fever Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Typhoid Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Typhoid Fever Vaccine Market by Type
    • 3.3.1: Live Attenuated Vaccine
    • 3.3.2: Capsular Polysaccharide Vaccine
    • 3.3.3: Conjugate Vaccine
    • 3.3.4: Others
  • 3.4: Global Typhoid Fever Vaccine Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Injection
  • 3.5: Global Typhoid Fever Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Specialty Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Typhoid Fever Vaccine Market by Region
  • 4.2: North American Typhoid Fever Vaccine Market
    • 4.2.2: North American Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
  • 4.3: European Typhoid Fever Vaccine Market
    • 4.3.1: European Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
    • 4.3.2: European Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
  • 4.4: APAC Typhoid Fever Vaccine Market
    • 4.4.1: APAC Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
    • 4.4.2: APAC Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
  • 4.5: ROW Typhoid Fever Vaccine Market
    • 4.5.1: ROW Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
    • 4.5.2: ROW Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Typhoid Fever Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Typhoid Fever Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Typhoid Fever Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Typhoid Fever Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: EMERGENT
  • 7.2: Bio Farma
  • 7.3: Bharat Biotech
  • 7.4: BIO-MED
  • 7.5: Pfizer
  • 7.6: GlaxoSmithKline
  • 7.7: Novartis
  • 7.8: Mylan
  • 7.9: Teva Pharmaceutical
  • 7.10: Sanofi